Sava I, Zhang F, Toma I, Theilacker C, Li B, Baumert T
J Biol Chem. 2009; 284(27):18194-201.
PMID: 19395379
PMC: 2709396.
DOI: 10.1074/jbc.M901460200.
Bolton R
Infect Immun. 1980; 30(3):723-7.
PMID: 7194866
PMC: 551375.
DOI: 10.1128/iai.30.3.723-727.1980.
Srivastava S, Barnum D
Can J Comp Med. 1982; 46(1):51-6.
PMID: 7074416
PMC: 1320195.
Beachey E, Simpson W
Infection. 1982; 10(2):107-11.
PMID: 7047404
DOI: 10.1007/BF01816738.
Stinson M, Bergey E
Infect Immun. 1982; 35(1):335-42.
PMID: 7033140
PMC: 351034.
DOI: 10.1128/iai.35.1.335-342.1982.
Characterization of lipoteichoic acid binding to polymorphonuclear leukocytes of human blood.
Courtney H, Ofek I, Simpson W, Beachey E
Infect Immun. 1981; 32(2):625-31.
PMID: 7019075
PMC: 351492.
DOI: 10.1128/iai.32.2.625-631.1981.
Fatty acid binding sites of serum albumin as membrane receptor analogs for streptococcal lipoteichoic acid.
Simpson W, Ofek I, Beachey E
Infect Immun. 1980; 29(1):119-22.
PMID: 6995332
PMC: 551083.
DOI: 10.1128/iai.29.1.119-122.1980.
Binding of streptococcal antigens to muscle tissue in vitro.
Stinson M, Nisengard R, Bergey E
Infect Immun. 1980; 27(2):604-13.
PMID: 6991420
PMC: 550807.
DOI: 10.1128/iai.27.2.604-613.1980.
Staphylococcal peptidoglycan: T-cell-dependent mitogen and relatively T-cell-independent polyclonal B-cell activator of human lymphocytes.
Levinson A, Dziarski A, Zweiman B, Dziarski R
Infect Immun. 1983; 39(1):290-6.
PMID: 6600446
PMC: 347939.
DOI: 10.1128/iai.39.1.290-296.1983.
Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein.
Weigent D, Beachey E, Huff T, Peterson J, STANTON G, Baron S
Infect Immun. 1984; 43(1):122-6.
PMID: 6418655
PMC: 263397.
DOI: 10.1128/iai.43.1.122-126.1984.
Bacteria-immune system interactions. V. Escherichia coli cell-wall components involved in binding to lymphocytes.
Shockley R, Kleinman R
Med Microbiol Immunol. 1983; 172(1):23-32.
PMID: 6348503
DOI: 10.1007/BF02123674.
Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin.
Courtney H, Simpson W, Beachey E
J Bacteriol. 1983; 153(2):763-70.
PMID: 6337126
PMC: 221695.
DOI: 10.1128/jb.153.2.763-770.1983.
Lipoteichoic acid is the major cell wall component responsible for surface hydrophobicity of group A streptococci.
Miorner H, Johansson G, Kronvall G
Infect Immun. 1983; 39(1):336-43.
PMID: 6337099
PMC: 347944.
DOI: 10.1128/iai.39.1.336-343.1983.
Interaction of bifidobacterial lipoteichoic acid with human intestinal epithelial cells.
Op den Camp H, Oosterhof A, Veerkamp J
Infect Immun. 1985; 47(1):332-4.
PMID: 3965407
PMC: 261519.
DOI: 10.1128/iai.47.1.332-334.1985.
Relationship of critical micelle concentrations of bacterial lipoteichoic acids to biological activities.
Courtney H, Simpson W, Beachey E
Infect Immun. 1986; 51(2):414-8.
PMID: 3943894
PMC: 262343.
DOI: 10.1128/iai.51.2.414-418.1986.
The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis.
Yamamoto A, Usami H, Nagamuta M, Sugawara Y, Hamada S, Yamamoto T
Br J Cancer. 1985; 51(5):739-42.
PMID: 3888244
PMC: 1977060.
DOI: 10.1038/bjc.1985.112.
Interaction of purified lipoteichoic acid with the classical complement pathway.
Loos M, Clas F, Fischer W
Infect Immun. 1986; 53(3):595-9.
PMID: 3488963
PMC: 260832.
DOI: 10.1128/iai.53.3.595-599.1986.
Stimulation of human monocyte chemiluminescence by staphylococcal lipoteichoic acid.
Ohshima Y, Beuth J, Yassin A, Ko H, Pulverer G
Med Microbiol Immunol. 1988; 177(3):115-21.
PMID: 3393118
DOI: 10.1007/BF00232891.
Bacterial lipoteichoic acid sensitizes host cells for destruction by autologous complement.
Hummell D, Winkelstein J
J Clin Invest. 1986; 77(5):1533-8.
PMID: 3084560
PMC: 424556.
DOI: 10.1172/JCI112468.
Stimulation of monokine production by lipoteichoic acids.
Bhakdi S, Klonisch T, Nuber P, Fischer W
Infect Immun. 1991; 59(12):4614-20.
PMID: 1937822
PMC: 259086.
DOI: 10.1128/iai.59.12.4614-4620.1991.